<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Digital Health &amp; Life Sciences | Clipperton</title>
	<atom:link href="https://www.clipperton.com/transaction/medtech-healthcare/feed" rel="self" type="application/rss+xml" />
	<link>https://www.clipperton.com/transaction/medtech-healthcare</link>
	<description>Clipperton is a leading independent investment bank fully focused on high-growth tech companies</description>
	<lastBuildDate>Thu, 26 Mar 2026 14:59:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.5</generator>

<image>
	<url>https://www.clipperton.com/wp-content/uploads/2024/07/cropped-CLIPPERTON-FAVICONE-10-07-2024-512-3-32x32.png</url>
	<title>Digital Health &amp; Life Sciences | Clipperton</title>
	<link>https://www.clipperton.com/transaction/medtech-healthcare</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Hublo welcomes Five Arrows as a new investor to accelerate the digitalisation of HR management in healthcare in Europe</title>
		<link>https://www.clipperton.com/transactions/hublo-welcomes-five-arrows-as-an-investor-to-accelerate-the-digitalisation-of-hr-management-in-healthcare-in-europe</link>
		
		<dc:creator><![CDATA[clipperton_admin]]></dc:creator>
		<pubDate>Wed, 18 Jun 2025 09:39:58 +0000</pubDate>
				<category><![CDATA[Transaction]]></category>
		<guid isPermaLink="false">https://www.clipperton.com/?post_type=transactions&#038;p=16497</guid>

					<description><![CDATA[<p>Clipperton acted as sole financial advisor to Hublo, a leading provider of digital HR solutions for the healthcare sector, on its investment by Five Arrows, the investment fund of Rothschild &#38; Co.&#160; Five Arrows will provide Hublo with long-term strategic and operational support, helping the company accelerate its growth – both organically and through acquisitions [&#8230;]</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/hublo-welcomes-five-arrows-as-an-investor-to-accelerate-the-digitalisation-of-hr-management-in-healthcare-in-europe">&lt;strong&gt;Hublo&lt;/strong&gt; welcomes Five Arrows as a new investor to accelerate the digitalisation of HR management in healthcare in Europe</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Clipperton acted as sole financial advisor to Hublo, a leading provider of digital HR solutions for the healthcare sector, on its investment by Five Arrows, the investment fund of Rothschild &amp; Co.&nbsp;</p>



<p>Five Arrows will provide Hublo with long-term strategic and operational support, helping the company accelerate its growth – both organically and through acquisitions &#8211; and amplify its impact in France and internationally.</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/hublo-welcomes-five-arrows-as-an-investor-to-accelerate-the-digitalisation-of-hr-management-in-healthcare-in-europe">&lt;strong&gt;Hublo&lt;/strong&gt; welcomes Five Arrows as a new investor to accelerate the digitalisation of HR management in healthcare in Europe</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Lauxera Capital Partners invests in Synovo</title>
		<link>https://www.clipperton.com/transactions/lauxera-invests-in-synovo</link>
		
		<dc:creator><![CDATA[clipperton_admin]]></dc:creator>
		<pubDate>Tue, 24 Sep 2024 09:13:21 +0000</pubDate>
				<category><![CDATA[Transaction]]></category>
		<guid isPermaLink="false">https://www.clipperton.com/?post_type=transactions&#038;p=14740</guid>

					<description><![CDATA[<p>Clipperton advised Lauxera Capital Partners as part of their minority investment in Synovo, a high-growth software editor for medical transport professionals.</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/lauxera-invests-in-synovo">&lt;strong&gt;Lauxera Capital Partners&lt;/strong&gt; invests in Synovo</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[
<p>Clipperton advised Lauxera Capital Partners as part of their minority investment in Synovo, a high-growth software editor for medical transport professionals.</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/lauxera-invests-in-synovo">&lt;strong&gt;Lauxera Capital Partners&lt;/strong&gt; invests in Synovo</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Kinvent secures a €16m Series B round with Eurazeo Nov Santé for its connected physiotherapy solution</title>
		<link>https://www.clipperton.com/transactions/kinvent-secures-a-e16m-series-b-round-with-eurazeo-nov-sante-for-its-connected-physiotherapy-solution</link>
		
		<dc:creator><![CDATA[clipperton_admin]]></dc:creator>
		<pubDate>Thu, 18 Jan 2024 08:23:02 +0000</pubDate>
				<category><![CDATA[Transaction]]></category>
		<guid isPermaLink="false">https://www.clipperton.com/?post_type=transactions&#038;p=7906</guid>

					<description><![CDATA[<p>Clipperton acted as sole financial advisor to Kinvent, the European leader in connected physiotherapy solutions, on its €16m growth financing led by Eurazeo Healthcare fund (Nov Santé), with the participation of existing minority shareholders including Unifund, Sofilaro, BADGE, and Raphaël Varane, among others. This is the third round of fundraising and will enable the company [&#8230;]</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/kinvent-secures-a-e16m-series-b-round-with-eurazeo-nov-sante-for-its-connected-physiotherapy-solution">&lt;strong&gt;Kinvent&lt;/strong&gt; secures a €16m Series B round with Eurazeo Nov Santé for its connected physiotherapy solution</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Clipperton acted as sole financial advisor to Kinvent, the European leader in connected physiotherapy solutions, on its €16m growth financing led by Eurazeo Healthcare fund (Nov Santé), with the participation of existing minority shareholders including Unifund, Sofilaro, BADGE, and Raphaël Varane, among others. This is the third round of fundraising and will enable the company to enter a new phase of acceleration, including market penetration in the United States in 2024 and increased effort on new R&amp;D projects.</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/kinvent-secures-a-e16m-series-b-round-with-eurazeo-nov-sante-for-its-connected-physiotherapy-solution">&lt;strong&gt;Kinvent&lt;/strong&gt; secures a €16m Series B round with Eurazeo Nov Santé for its connected physiotherapy solution</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Tilak Healthcare raised €10m led by Elaia and Cap Horn</title>
		<link>https://www.clipperton.com/transactions/tilak-healthcare-raised-e10m-led-by-elaia-and-cap-horn</link>
		
		<dc:creator><![CDATA[clipperton_admin]]></dc:creator>
		<pubDate>Thu, 12 Oct 2023 09:45:34 +0000</pubDate>
				<category><![CDATA[Transaction]]></category>
		<guid isPermaLink="false">https://www.clipperton.com/?post_type=transactions&#038;p=7675</guid>

					<description><![CDATA[<p>Clipperton acted as sole financial advisor to Tilak Healthcare on its €10m growth financing led by Cap Horn and Elaia Partners, with the participation of historical investors Swen Capital Partners and iBionext Growth Fund &#8211; joined by Laboratoires Théa, the flagship of French ophthalmology &#8211; as well as Adelie, and several renowned ophthalmologists and Business [&#8230;]</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/tilak-healthcare-raised-e10m-led-by-elaia-and-cap-horn">&lt;strong&gt;Tilak Healthcare&lt;/strong&gt; raised €10m led by Elaia and Cap Horn</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Clipperton acted as sole financial advisor to Tilak Healthcare on its €10m growth financing led by Cap Horn and Elaia Partners, with the participation of historical investors Swen Capital Partners and iBionext Growth Fund &#8211; joined by Laboratoires Théa, the flagship of French ophthalmology &#8211; as well as Adelie, and several renowned ophthalmologists and Business Angels, including Yann Fleureau (co-founder of Cardiologs). The funds will be used to accelerate the deployment of OdySight in France and internationally and to develop new solutions for other pathologies.</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/tilak-healthcare-raised-e10m-led-by-elaia-and-cap-horn">&lt;strong&gt;Tilak Healthcare&lt;/strong&gt; raised €10m led by Elaia and Cap Horn</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Merieux Equity Partners leads a $150m growth financing round in DentalMonitoring, France&#8217;s new HealthTech Unicorn</title>
		<link>https://www.clipperton.com/transactions/merieux-equity-partners-leads-a-150m-growth-financing-round-in-dentalmonitoring</link>
		
		<dc:creator><![CDATA[clipperton_admin]]></dc:creator>
		<pubDate>Thu, 21 Oct 2021 08:38:50 +0000</pubDate>
				<category><![CDATA[Transaction]]></category>
		<guid isPermaLink="false">https://www.clipperton.com/?post_type=transactions&#038;p=6041</guid>

					<description><![CDATA[<p>Clipperton acted as exclusive financial advisor to Merieux Equity Partners on a $150m growth financing round of DentalMonitoring. Co-founded in 2014 by Philippe Salah, DentalMonitoring is the 1st company globally to offer an AI-based solution that empowers dentists and orthodontists to expand their practice into a virtual environment. Through this capital increase, DentalMonitoring joins France’s [&#8230;]</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/merieux-equity-partners-leads-a-150m-growth-financing-round-in-dentalmonitoring">&lt;strong&gt;Merieux Equity Partners&lt;/strong&gt; leads a $150m growth financing round in DentalMonitoring, France&#8217;s new HealthTech Unicorn</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span style="font-weight: 400;">Clipperton acted as exclusive financial advisor to Merieux Equity Partners on a $150m growth financing round of DentalMonitoring.</span></p>
<p><span style="font-weight: 400;">Co-founded in 2014 by Philippe Salah, DentalMonitoring is the 1st company globally to offer an AI-based solution that empowers dentists and orthodontists to expand their practice into a virtual environment.</span></p>
<p><span style="font-weight: 400;">Through this capital increase, </span><span style="font-weight: 400;">DentalMonitoring joins France’s “Unicorn Club” as the 2nd French HealthTech company reaching the $1bn valuation mark.</span></p>
<p>This transaction illustrates Clipperton’s expertise and rich track record in the digital health space after <a href="https://www.clipperton.com/transactions/inova-receives-a-70-million-investment-from-carlyle">Inova’s $70m growth investment with Carlyle</a> earlier this year and <a href="https://www.clipperton.com/transactions/withings-reaches-a-major-milestone-with-a-60m-financing-round-led-by-healthcare-specialist-fund-gilde-healthcare-idinvest-partners-and-bpifrance">Withings’ $60m round led by Gilde Healthcare, Eurazeo and Bpifrance</a>.</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/merieux-equity-partners-leads-a-150m-growth-financing-round-in-dentalmonitoring">&lt;strong&gt;Merieux Equity Partners&lt;/strong&gt; leads a $150m growth financing round in DentalMonitoring, France&#8217;s new HealthTech Unicorn</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Inpart (formerly Inova) receives a $70 million growth investment from Carlyle [NASDAQ: CG] and NextStage</title>
		<link>https://www.clipperton.com/transactions/inova-receives-a-70-million-investment-from-carlyle</link>
		
		<dc:creator><![CDATA[clipperton_admin]]></dc:creator>
		<pubDate>Thu, 01 Jul 2021 10:22:15 +0000</pubDate>
				<category><![CDATA[Transaction]]></category>
		<guid isPermaLink="false">https://www.clipperton.com/?post_type=transactions&#038;p=5657</guid>

					<description><![CDATA[<p>Clipperton acted as the exclusive advisor to Inova and its shareholders. Carlyle’s and NextStage&#8217;s investment will enable Inova to accelerate its growth, fund product innovation and M&#38;A initiatives. Trusted by the largest and most innovative life science companies globally, Inova’s SaaS platform is uniquely positioned between large pharmaceutical companies and biotechs to accelerate and foster [&#8230;]</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/inova-receives-a-70-million-investment-from-carlyle">&lt;strong&gt;Inpart&lt;/strong&gt; (formerly Inova) receives a $70 million growth investment from Carlyle [NASDAQ: CG] and NextStage</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Clipperton acted as the exclusive advisor to Inova and its shareholders. Carlyle’s and NextStage&#8217;s investment will enable Inova to accelerate its growth, fund product innovation and M&amp;A initiatives.</p>
<p><span style="font-weight: 400;">Trusted by the largest and most innovative life science companies globally, </span><a href="https://inova.io/"><span style="font-weight: 400;">Inova</span></a><span style="font-weight: 400;">’s SaaS platform is uniquely positioned between large pharmaceutical companies and biotechs to accelerate and foster successful collaboration on life science innovation and R&amp;D. Its advanced specialized product suite offers biopharma companies with the perfect tools to source, qualify and manage licensing and collaborations.</span></p>
<p><span style="font-weight: 400;">This transaction highlights Clipperton’s sector expertise in both SaaS, following deals such as </span><a href="https://www.clipperton.com/transactions/innosabi-questel-acquisition-of-a-majority-stake"><span style="font-weight: 400;">innosabi</span></a><span style="font-weight: 400;"> (sold to Questel), </span><a href="https://www.clipperton.com/transactions/sendinblue-raises-160m-in-series-b-funding"><span style="font-weight: 400;">Sendinblue</span></a><span style="font-weight: 400;"> ($160m round with Bridgepoint, BlackRock and Bpifrance) and <a href="https://www.clipperton.com/transactions/lengow-receives-a-growth-investment-from-marlin-equity-partners">Lengow</a> (received a growth investment from Marlin Equity Partners)</span>, and Healthtech, following deals such as <a href="https://www.clipperton.com/transactions/withings-reaches-a-major-milestone-with-a-60m-financing-round-led-by-healthcare-specialist-fund-gilde-healthcare-idinvest-partners-and-bpifrance">Withings</a> ($60m round with Gilde Healthcare, Idinvest Partners and Bpifrance), and <a href="https://www.clipperton.com/transactions/endospan-receives-25m-from-cryolife">Endospan</a> ($25m round led by Cryolife).</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/inova-receives-a-70-million-investment-from-carlyle">&lt;strong&gt;Inpart&lt;/strong&gt; (formerly Inova) receives a $70 million growth investment from Carlyle [NASDAQ: CG] and NextStage</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Endospan receives $25m from Cryolife</title>
		<link>https://www.clipperton.com/transactions/endospan-receives-25m-from-cryolife</link>
		
		<dc:creator><![CDATA[clipperton_admin]]></dc:creator>
		<pubDate>Fri, 25 Oct 2019 14:25:02 +0000</pubDate>
				<category><![CDATA[Transaction]]></category>
		<guid isPermaLink="false">https://www.clipperton.com/?post_type=transactions&#038;p=2222</guid>

					<description><![CDATA[<p>Endospan, an innovative Israeli-based Aortic Arch medical device company, secures a $25 million financing from CryoLife [NYSE:CRY]. Clipperton acted as sole financial advisor to Endospan. This transaction highlights Clipperton expertise in cross-border transactions after a series of completed deals within the last 12 months – e.g. NetRange (DE) /Access Co (JP), Musement (IT) / TUI [&#8230;]</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/endospan-receives-25m-from-cryolife">&lt;strong&gt;Endospan&lt;/strong&gt; receives $25m from Cryolife</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Endospan, an innovative Israeli-based Aortic Arch medical device company, secures a $25 million financing from CryoLife [NYSE:CRY].</p>
<p>Clipperton acted as sole financial advisor to Endospan.</p>
<p>This transaction highlights Clipperton expertise in cross-border transactions after a series of completed deals within the last 12 months – e.g. <a href="https://www.clipperton.com/transactions/netrange-sold-to-acces-europe-gmbh">NetRange (DE) /Access Co (JP)</a>, <a href="https://www.clipperton.com/transactions/online-tours-attractions-musement-sold-travel-giant-tui-group">Musement (IT) / TUI (DE)</a>, Vide Dressing (FR) /Adevinta (NO), <a href="https://www.clipperton.com/transactions/german-fintech-startup-givve-sold-to-up-group">Givve (DE) / Up Group (FR)</a>, <a href="https://www.clipperton.com/transactions/wireless-logic-acquires-french-iot-start-matooma">Matooma (FR) / Wireless Logic Group (UK)</a>.</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/endospan-receives-25m-from-cryolife">&lt;strong&gt;Endospan&lt;/strong&gt; receives $25m from Cryolife</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Ibex raises $11 million to deploy the first AI-driven cancer diagnosis system</title>
		<link>https://www.clipperton.com/transactions/ibex-medical-raises-11-million-series-fuel-growth-2</link>
		
		<dc:creator><![CDATA[clipperton_admin]]></dc:creator>
		<pubDate>Mon, 15 Jul 2019 14:21:15 +0000</pubDate>
				<category><![CDATA[Transaction]]></category>
		<guid isPermaLink="false">https://www.clipperton.com/?post_type=transactions&#038;p=1779</guid>

					<description><![CDATA[<p>Israel-based HealthTech VC aMoon leads this $11 million financing round, backed by 83North, Dell Technologies Capital and existing investor Kamet Ventures (Axa&#8217;s venture arm). Ibex will use the funds to go through the development of its solution for other pathologies and start international expansion. First deal closed by Clipperton in Israel.</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/ibex-medical-raises-11-million-series-fuel-growth-2">&lt;strong&gt;Ibex&lt;/strong&gt; raises $11 million to deploy the first AI-driven cancer diagnosis system</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Israel-based HealthTech VC <a href="https://amoon.fund/" target="_blank" rel="noopener noreferrer">aMoon</a> leads this $11 million financing round, backed by <a href="https://www.83north.com/" target="_blank" rel="noopener noreferrer">83North</a>, <a href="https://www.delltechnologies.com/fr-fr/capital.htm" target="_blank" rel="noopener noreferrer">Dell Technologies Capital</a> and existing investor <a href="https://www.kametventures.com/" target="_blank" rel="noopener noreferrer">Kamet Ventures</a> (Axa&#8217;s venture arm).</p>
<p><a href="https://ibex-ai.com/" target="_blank" rel="noopener noreferrer">Ibex</a> will use the funds to go through the development of its solution for other pathologies and start international expansion.</p>
<p>First deal closed by Clipperton in Israel.</p>
<p>Cet article <a href="https://www.clipperton.com/transactions/ibex-medical-raises-11-million-series-fuel-growth-2">&lt;strong&gt;Ibex&lt;/strong&gt; raises $11 million to deploy the first AI-driven cancer diagnosis system</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dental Monitoring receives €45m from Vitruvian Partners</title>
		<link>https://www.clipperton.com/transactions/dental-monitoring-receives-e45m-from-vitruvian-partners</link>
		
		<dc:creator><![CDATA[clipperton_admin]]></dc:creator>
		<pubDate>Mon, 11 Mar 2019 15:52:21 +0000</pubDate>
				<category><![CDATA[Transaction]]></category>
		<guid isPermaLink="false">https://www.clipperton.com/?post_type=transactions&#038;p=4284</guid>

					<description><![CDATA[<p>Cet article <a href="https://www.clipperton.com/transactions/dental-monitoring-receives-e45m-from-vitruvian-partners">&lt;strong&gt;Dental Monitoring&lt;/strong&gt; receives €45m from Vitruvian Partners</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Cet article <a href="https://www.clipperton.com/transactions/dental-monitoring-receives-e45m-from-vitruvian-partners">&lt;strong&gt;Dental Monitoring&lt;/strong&gt; receives €45m from Vitruvian Partners</a> est apparu en premier sur <a href="https://www.clipperton.com">Clipperton Finance</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
